Trials / Completed
CompletedNCT00703183
Safety and Tolerability of ACU-4429
A Single Center, Randomized, Double-Masked, Dose-Escalating, Placebo-Controlled Study of the Safety and Tolerability ACU-4429 in Healthy Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 46 (actual)
- Sponsor
- Kubota Vision Inc. · Industry
- Sex
- All
- Age
- 55 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate the safety and tolerability of a new investigational drug (ACU-4429) in healthy human volunteers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ACU-4429 | administered as a single dose, orally |
| DRUG | matching placebo | administered as a single dose, orally |
Timeline
- Start date
- 2008-05-01
- Primary completion
- 2009-06-01
- Completion
- 2009-06-01
- First posted
- 2008-06-23
- Last updated
- 2012-06-27
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00703183. Inclusion in this directory is not an endorsement.